Mass Spectrometry in Cerebrospinal Fluid Uncovers Association of Glycolysis Biomarkers with Alzheimer’s Disease in a Large Clinical Sample

BACKGROUND: Alzheimer’s disease (AD) is a complex heterogenous neurodegenerative disorder, characterized by multiple pathophysiologies, including disruptions in brain metabolism. Defining markers for patient stratification across these pathophysiologies is an important step towards personalized trea...

Descripción completa

Detalles Bibliográficos
Autores principales: de Geus, Matthijs B., Leslie, Shannon N., Lam, TuKiet, Wang, Weiwei, Kivisakk, Pia, Nairn, Angus C., Arnold, Steven E., Carlyle, Becky C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350182/
https://www.ncbi.nlm.nih.gov/pubmed/37461556
http://dx.doi.org/10.21203/rs.3.rs-3073597/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350182/
https://www.ncbi.nlm.nih.gov/pubmed/37461556
http://dx.doi.org/10.21203/rs.3.rs-3073597/v1

Ejemplares similares